# Boston Scientific to acquire BTG for $4.2bn

Boston Scientific signed an agreement to acquire UK-based BTG for $4.2bn. The deal is expected to close mid-2019 after antitrust clearance.

- Type: Acquisition
- Announced: 2019-02-18
- Where: United States
- Value: $4.20B
- Status: announced
- Products: therapeutic beads, products for critical care, cancer and vascular diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [BTG Plc](https://endata.com/companies/34199.md) (target)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/ftc-boston-scientific-btg-acquisition/), 2019-02-18: "The acquisition is expected to boost Boston Scientific’s capabilities in areas of unmet need such as cancer and pulmonary embolism."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
